Yahoo Web Search

Search results

1. • AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review

     ETF DAILY NEWS· 17 hours ago

     AbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment ...

2. • 

     US pharma giant Cencora says Americans' health information stolen in data breach

     TechCrunch· 1 day ago

     U.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...

3. • AbbVie (NYSE:ABBV) Shares Down 0.1%

     ETF DAILY NEWS· 10 hours ago

     AbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately ...

4. • 

     Cencora data breach exposes US patient info from 8 drug companies

     BleepingComputer· 1 day ago

     Cencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...

5. • This Is What Whales Are Betting On AbbVie - AbbVie (NYSE:ABBV)

     Benzinga· 3 days ago

     The company was spun off from Abbott in early 2013. The 2020...

6. • 

     After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...

     Benzinga via AOL· 1 day ago

     U.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...

7. • AbbVie Files Notice of Data Breach Impacting the Health Information of Tens of Thousands of...

     JD Supra· 3 days ago

     On May 22, 2024, AbbVie, Inc. filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had been entrusted to the ...

8. • 

     2 Billion More Reasons to Buy AbbVie Stock

     Motley Fool via Yahoo Finance· 3 days ago

     Here's why. This new segment could be incredibly valuable On May 13, AbbVie signed a deal with the biotech Gilgamesh Pharmaceuticals to collaborate on...

9. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 10 hours ago

     NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between (Nasdaq: CERE) Cerevel Therapeutics Holdings, Inc. and AbbVie ...

10. • 

      FTC Oversight of Pharmaceutical Sector 'Minimal' Over Last 20-Plus Years

      MedPage Today· 6 days ago

      The Federal Trade Commission (FTC) pursued about one merger action and three enforcement actions per...